SCHEMBL4386658

SCHEMBL4386658

COC(=O)Cc1c(Cc2ccccc2)c(O)cc(O)c1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.47
HSP90AA1 P07900 5/20 0.41
ABCB1 P08183 1/20 0.41
NPC1 O15118 1/20 0.40
PKM P14618 1/20 0.40
HPGD P15428 1/20 0.40
NFKB1 P19838 1/20 0.40
RAB9A P51151 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALDH1A1 P00352 3/20 0.40
GAA P10253 1/20 0.40
GFER P55789 1/20 0.40
KDM4E B2RXH2 2/20 0.39
LMNA P02545 1/20 0.39
HSP90AB1 P08238 1/20 0.39
SLC7A5 Q01650 1/20 0.39
CYP1A2 P05177 1/20 0.38
THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4385993 0.87 L3MBTL1 (0.48) L3MBTL1NPC1PKMHPGDNFKB1
SCHEMBL4380942 0.86 L3MBTL1 (0.43) L3MBTL1NPC1PKMHPGDNFKB1
SCHEMBL4384837 0.82 L3MBTL1 (0.44) L3MBTL1NPC1PKMHPGDNFKB1
SCHEMBL4378331 0.82 L3MBTL1 (0.42) L3MBTL1NPC1PKMHPGDNFKB1
SCHEMBL4379801 0.81 L3MBTL1 (0.43) L3MBTL1NPC1PKMHPGDNFKB1
SCHEMBL4387620 0.81 L3MBTL1 (0.43) L3MBTL1NPC1PKMHPGDNFKB1
SCHEMBL4394063 0.80 L3MBTL1 (0.43) L3MBTL1NPC1PKMHPGDNFKB1
SCHEMBL4380484 0.78 ALDH1A1 (0.42) L3MBTL1NPC1PKMHPGDNFKB1
SCHEMBL4393857 0.77 EGFR (0.44) L3MBTL1NPC1PKMHPGDNFKB1
SCHEMBL4388407 0.77 ALDH1A1 (0.48) L3MBTL1HSP90AA1HPGDALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P L3MBTL1 3218/4885HSP90AA1 5/4885ABCB1 204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.